Skip to content

Reflotron Creatinine Test Tabs

by Boehringer Mannheim Corp. 510(k)

Active United States

510(k) K913105

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK913105 Date12 Aug 1991ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
JFY
Device Class
Class II
Regulation
21 CFR Part 862.1225
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Reflotron Creatinine Test Tabs are a diagnostic in vitro device classified as an enzymatic method for creatinine measurement. These test tabs utilize a colorimetric assay to quantify creatinine levels in serum or plasma, aiding in the assessment of renal function and detection of conditions such as chronic kidney disease or acute renal failure.

Supplied as single-use test tabs, the device is intended for use in clinical chemistry laboratories and point-of-care settings. Each tab is designed for one-time use and requires no additional reagents beyond the sample. The product is regulated under FDA 510(k) clearance (K913105) and falls under product code JFY, classified as Class II with special controls. Storage conditions are not specified in the data, but standard laboratory practices for in vitro diagnostics should be followed.

Other devices from Boehringer Mannheim Corp.

See all devices from Boehringer Mannheim Corp. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Reflotron Creatinine Test Tabs used for?

    The Reflotron Creatinine Test Tabs are an in vitro diagnostic device that uses an enzymatic colorimetric assay to measure creatinine levels in serum or plasma, aiding in the assessment of renal function and detection of conditions such as chronic kidney disease or acute renal failure.

  • How is the Reflotron Creatinine Test Tabs supplied and is it reusable?

    The device is supplied as single-use test tabs, with each tab designed for one-time use only and requiring no additional reagents beyond the patient sample, making it unsuitable for reuse.

  • What regulatory pathway was used for the Reflotron Creatinine Test Tabs?

    The Reflotron Creatinine Test Tabs received FDA 510(k) clearance under submission K913105, classified as substantially equivalent to a predicate device, and is regulated as a Class II medical device with special controls under product code JFY.

  • In what settings is the Reflotron Creatinine Test Tabs intended to be used?

    The device is intended for use in clinical chemistry laboratories and point-of-care settings, where rapid creatinine measurement is needed to support renal function assessment.

  • What special controls apply to the Reflotron Creatinine Test Tabs based on its classification?

    As a Class II device under product code JFY for enzymatic creatinine measurement, the Reflotron Creatinine Test Tabs are subject to special controls, which include performance standards, labeling requirements, and post-market surveillance as mandated by FDA regulation 862.1225.